Step Therapy Approval Criteria

Similar documents
Step Therapy Approval Criteria

Step Therapy Approval Criteria

Step Therapy Approval Criteria

FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS

FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS

NB Drug Plans Formulary Update

INFLIXIMAB Remicade (infliximab), Inflectra (infliximab-dyyb), Ixifi* (infliximabqbtx), Renflexis (infliximab-abda)

HARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES

Pharmacy Updates Summary

Step Therapy Requirements. Effective: 12/01/2016

Alprazolam 0.25mg, 0.5mg, 1mg tablets

1 P a g e. Systemic Juvenile Idiopathic Arthritis (SJIA) (1.3) Patients 2 years of age and older with active systemic juvenile idiopathic arthritis.

ADHD STIMULANTS-S(SHC)

Immune Modulating Drugs Prior Authorization Request Form

Michigan Department of Community Health Quantity Limitations

ETANERCEPT Generic Brand HICL GCN Exception/Other ETANERCEPT ENBREL GUIDELINES FOR USE INITIAL CRITERIA (NOTE: FOR RENEWAL CRITERIA SEE BELOW)

Otezla. Otezla (apremilast) Description

Step Therapy Criteria

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

**CRITERIA UNDER CMS REVIEW**

ANTIDIABETIC AGENTS - MISCELLANEOUS

Upper Peninsula Health Plan Advantage (HMO) (List of Covered Drugs)

Relative Cost/Month. Less than $10. Loratadine Liquid* $10-$15 Cetirizine liquid 1mg/mL*

Regulatory Status FDA-approved indications: Entyvio is an α4β7integrin receptor antagonist indicated for: (1)

USTEKINUMAB Generic Brand HICL GCN Exception/Other USTEKINUMAB STELARA GUIDELINES FOR USE

Step Therapy Requirements. Effective: 1/1/2019

Step Therapy Requirements. Effective: 03/01/2015

ANTIDEPRESSANTS. Details. Step Therapy 2018 Last Updated: 8/21/2018

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

2. Has the patient had a response to treatment? Y N. 3. Does the patient have a diagnosis of rheumatoid arthritis (RA)? Y N

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

ANTIDIABETIC AGENTS - MISCELLANEOUS

CRITERIA Trial of two generic formulary products from the following: atomoxetine or ADHD stimulant medication.

ANTIDIABETIC AGENTS - MISCELLANEOUS

HARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES HUMIRA PEDIATRIC

Index. Note: Page numbers of article titles are in boldface type.

ANTICONVULSANTS. Details

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 04/01/2019

HARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017

Formulary Updates to DHMP Commercial Plans (POS/DMC/DMC-E/CSA/DERP/DPPA & DHMO:CSA/DERP/DPPA)

CMI Marketplace 2015 (List of Covered Drugs)

WELLCARE/ OHANA HEALTH PLAN 2015 STEP THERAPY CRITERIA (No Changes Made Since: 08/2015)

2017 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

ANTIDEPRESSANTS. Details. Step Therapy 2017 Last Updated: 5/23/2017

ANTICONVULSANTS. Details

Exclusion Criteria. Required Medical Documentation

Step Therapy Criteria

Fml Limits. Azathioprine (Imuran) 50mg, 75mg, 100mg - $26.85 Cyclosporine, 25mg, 100mg. $ Leflunomide (Arava) 10mg Tablet - $144.

CIMZIA (certolizumab pegol)

Medicare Part D Drugs that Require Step Therapy Effective 12/01/2017

Leitner Christian. Best Selling Drugs

Drug Class Prior Authorization Criteria Therapeutic Agents in Rheumatic and Inflammatory Diseases

A. Correct! Nociceptors are pain receptors stimulated by harmful stimuli, resulting in the sensation of pain.

Michigan Department of Community Health Co-pay and Quantity Limitations

ANTIDEPRESSANTS. Details. dose pack Viibryd 10 mg tablet Viibryd 20 mg tablet Viibryd 40 mg tablet. Criteria

Step Therapy Requirements

ANTICONVULSANTS. Details

SASKATCHEWAN FORMULARY COMMITTEE BULLETIN 55th EDITION

ANTICONVULSANTS. Details

BIOANALYTICAL ASSAY LIST

Clinical Policy: Certolizumab (Cimzia) Reference Number: CP.PHAR.247 Effective Date: Last Review Date: Line of Business: HIM, Medicaid

Step Therapy Requirements. Effective: 05/01/2018

Approximate Cost for Patients

Your prescription benefit updates Formulary Updates - Effective January 1, 2019

STEP THERAPY CRITERIA

First Name. Specialty: Fax. First Name DOB: Duration:

FirstCarolinaCare Insurance Company. Step Therapy Requirements

Palliative Care Drug Plan (Plan P) Formulary List of drugs PharmaCare covers

Santa Clara Family Health Plan Cal MediConnect Formulary. List of Step Therapy Requirements Effective: 12/01/ E

ABILIFY INJ. Products Affected Step 2: ABILIFY MAINTENA PREFILLED SYRINGE 300 MG INTRAMUSCULAR ABILIFY MAINTENA PREFILLED SYRINGE 400 MG INTRAMUSCULAR

WellCare Signature (PDP) and WellCare Classic (PDP) Formulary Addendum

ADALIMUMAB Generic Brand HICL GCN Exception/Other ADALIMUMAB HUMIRA GUIDELINES FOR USE INITIAL CRITERIA (NOTE: FOR RENEWAL CRITERIA SEE BELOW)

Step Therapy Requirements. Effective: 11/01/2018

5-ASA. Products Affected DIPENTUM 250 MG CAPSULE LIALDA 1.2 GRAM TABLET,DELAYED RELEASE. Details

Garrick Brown, MD. Digestive Health Specialists Tacoma Gig Harbor

5-ASA. Products Affected. Details. Dipentum 250 mg capsule. Lialda 1.2 gram tablet,delayed release

Acyclovir Ointment. Aetna Better Health Pennsylvania. Products Affected. acyclovir ointment 5 % external Details. Criteria

Circle Yes or No Y N. [If no, skip to question 7.] 2. Does the patient have a diagnosis of ulcerative colitis? Y N. [If no, skip to question 4.

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017

Regulatory Status FDA- approved indication: Simponi and Simponi ARIA are tumor necrosis factor (TNF) blockers indicated for the treatment of: (2-3)

1. Background: Infliximab is administered parenterally; therefore, it is not covered under retail pharmacy benefits.

Follow-up to Previous Reviews. Foster Children Prescribers (Nurse Practitioner Practice Sites)

Clinical Policy: Apremilast (Otezla) Reference Number: CP.PHAR.245 Effective Date: Last Review Date: Line of Business: HIM, Medicaid

ALLERGIC CONJUNCTIVITIS AGENTS

Helpline No:

Xeljanz. Xeljanz, Xeljanz XR (tofacitinib) Description

Buckeye Health Plan Medicaid Criteria Updates Q1 2017

WR Fentanyl Symposium. Opioids, Overdose, and Fentanyls

Transcription:

Effective Date: 01/01/2019 This document contains for the following medications: 1. Colcrys (colchicine) 2. Dovonex (calcipotriene) 3. Enbrel (etanercept) 4. Humira (adalimumab) 5. Imitrex Injection vial and STATdose (sumatriptan succinate) 6. Jardiance (empagliflozin) 7. Levitra (vardenafil) 8. Lyrica (pregabalin) 9. Nexium (esomeprazole) 10. OxyContin (oxycodone extended-release) 11. Protopic (tacrolimus) 12. Relpax (eletriptan) 13. Risperdal Consta (risperidone long-acting injection) 14. Soriatane (acitretin) 15. Victoza (liraglutide) 16. Vyvanse (lisdexamfetamine) 17. Xifaxan (rifaximin)

Colcrys (colchicine) colchicine Colcrys Antigout; antiinflammatory Previous failure of one of the following in the past 365 days: o A formulary NSAID o A formulary glucocorticoid o Allopurinol o Probenecid/colchicine Quantity Limit (QL) of 60 tablets per 30 days Initial: October 2016

Dovonex (calcipotriene) calcipotriene Dovonex Antipsoriatic, Synthetic Vitamin D3 Previous failure of a formulary topical corticosteroid in the past 365 days Initial: January 2016

Enbrel (etanercept) etanercept Enbrel TNF inhibitor; immune suppressant Previous failure of one of the following in the past 365 days: o Asacol o Balsalazide o Dipentum o Methotrexate o Rowasa o Azathioprine o Cyclosporine o Hydroxychloroquine o Hydroxyurea o Leflunomide o Mercaptopurine o Soriatane o Sulfasalazine Quantity limit (QL) of 4 injections per 28 days Initial: 10/01/2013 04/01/2015, 10/01/2016

Humira (adalimumab) adalimumab Humira TNF inhibitor; monoclonal antibody; antirheumatic Previous failure of one of the following in the past 365 days: o Asacol o Balsalazide o Dipentum o Methotrexate o Rowasa o Azathioprine o Cyclosporine o Hydroxychloroquine o Hydroxyurea o Leflunomide o Mercaptopurine o Soriatane o Sulfasalazine Quantity limit (QL) of 4 injections per 28 days Initial: 10/01/2013 04/01/2015, 10/01/2016

Imitrex Injection vial and STATdose (sumatriptan succinate) sumatriptan Imitrex Injection vial and Imitrex STATdose 5HT-1 serotonin receptor agonist; antimigraine Previous failure of sumatriptan oral tablets or sumatriptan nasal spray in the past 365 days Quantity limit (QL) of 6 doses (3 ml) per 30 days Initial: 10/01/2013

Jardiance (empagliflozin) empagliflozin Jardiance SGLT2 inhibitor Previous failure of a formulary diabetes medication in the past 365 days. Initial: July 2017

Levitra (vardenafil) Brand names: vardenafil Levitra Phosphodiesterase-5 (PDE-5) inhibitor Previous failure of sildenafil citrate (generic for Viagra) in the past 365 days Quantity Limit (QL) of 6 tablets per 30 days Initial: July 2018

Lyrica (pregabalin) pregabalin Lyrica GABA analog; anticonvulsant Previous failure of gabapentin or duloxetine in the past 365 days Initial: January 2019

Nexium (esomeprazole) esomeprazole Nexium Proton pump inhibitor Previous failure of omeprazole or pantoprazole in the past 365 days Quantity Limit (QL) of 30 capsules per 30 days Initial: 01/01/2015 04/01/2015, 04/01/2018

OxyContin (oxycodone extended-release) oxycodone extended-release OxyContin Opioid analgesic Previous failure of one formulary long-acting opioid analgesic (i.e. morphine sulfate extended-release, fentanyl patches or methadone) in the past 365 days. Initial: January 2018

Protopic (tacrolimus) Brand names: tacrolimus Protopic Calcineurin inhibitor Previous failure of one formulary topical corticosteroid in the past 365 days Quantity Limit (QL) of 100 grams per 30 days Initial: April 2017

Relpax (eletriptan) eletriptan Relpax 5-HT1 serotonin receptor agonist; antimigraine Previous failure of a formulary triptan medication (sumatriptan tablet, sumatriptan nasal spray, sumatriptan injection, zolmitriptan tablet or zolmitriptan oral-disintegrating tablet) in the past 180 days Quantity limit (QL) of 6 tablets per 30 days Initial: 10/01/2013

Risperdal Consta (risperidone long-acting injectable) risperidone long-acting injectable Risperdal Consta Atypical antipsychotic Previous failure of risperidone tablets in the past 365 days. Initial: July 2017

Soriatane (acitretin) acitretin Soriatane Retinoid Previous failure of methotrexate in the past 365 days. Initial: October 2016

Victoza (liraglutide) liraglutide Victoza GLP-1 receptor agonist Previous failure of a formulary diabetes medication in the past 365 days. Initial: January 2018

Vyvanse (lisdexamfetamine) lisdexamfetamine Vyvanse CNS stimulant Previous failure of a formulary generic amphetamine product in the past 365 days Step 2: Previous failure of formulary generic methylphenidate product in the past 365 days Quantity Limit (QL) of 30 capsules per 30 days Initial: April 2017

Xifaxan (rifaximin) rifaximin Xifaxan Rifamycin Previous failure of lactulose, dicyclomine, ciprofloxacin or azithromycin in the past 180 days Quantity limit (QL) of 60 tablets per 30 days for the 550 mg tablets Quantity limit (QL) of 180 tablets per 30 days for the 200 mg tablets Initial: 07/01/2015 October 2017